15-89295005-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BA1
The NM_001113378.2(FANCI):c.2547A>G(p.Lys849Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0497 in 1,552,292 control chromosomes in the GnomAD database, including 2,369 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.040 ( 214 hom., cov: 32)
Exomes 𝑓: 0.051 ( 2155 hom. )
Consequence
FANCI
NM_001113378.2 synonymous
NM_001113378.2 synonymous
Scores
1
Clinical Significance
Conservation
PhyloP100: 1.72
Publications
25 publications found
Genes affected
FANCI (HGNC:25568): (FA complementation group I) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group I. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
FANCI Gene-Disease associations (from GenCC):
- Fanconi anemia complementation group IInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.19).
BP6
Variant 15-89295005-A-G is Benign according to our data. Variant chr15-89295005-A-G is described in ClinVar as Benign. ClinVar VariationId is 238316.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.72 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0515 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FANCI | NM_001113378.2 | c.2547A>G | p.Lys849Lys | synonymous_variant | Exon 24 of 38 | ENST00000310775.12 | NP_001106849.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FANCI | ENST00000310775.12 | c.2547A>G | p.Lys849Lys | synonymous_variant | Exon 24 of 38 | 1 | NM_001113378.2 | ENSP00000310842.8 |
Frequencies
GnomAD3 genomes AF: 0.0403 AC: 6133AN: 152158Hom.: 214 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6133
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0507 AC: 70951AN: 1400016Hom.: 2155 Cov.: 31 AF XY: 0.0497 AC XY: 34286AN XY: 690480 show subpopulations
GnomAD4 exome
AF:
AC:
70951
AN:
1400016
Hom.:
Cov.:
31
AF XY:
AC XY:
34286
AN XY:
690480
show subpopulations
African (AFR)
AF:
AC:
217
AN:
31600
American (AMR)
AF:
AC:
570
AN:
35708
Ashkenazi Jewish (ASJ)
AF:
AC:
863
AN:
25182
East Asian (EAS)
AF:
AC:
4
AN:
35740
South Asian (SAS)
AF:
AC:
1774
AN:
79234
European-Finnish (FIN)
AF:
AC:
6152
AN:
49564
Middle Eastern (MID)
AF:
AC:
104
AN:
5702
European-Non Finnish (NFE)
AF:
AC:
58925
AN:
1079102
Other (OTH)
AF:
AC:
2342
AN:
58184
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
4038
8076
12115
16153
20191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2228
4456
6684
8912
11140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0403 AC: 6133AN: 152276Hom.: 214 Cov.: 32 AF XY: 0.0425 AC XY: 3166AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
6133
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
3166
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
366
AN:
41560
American (AMR)
AF:
AC:
328
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
121
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5188
South Asian (SAS)
AF:
AC:
98
AN:
4826
European-Finnish (FIN)
AF:
AC:
1504
AN:
10588
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3603
AN:
68020
Other (OTH)
AF:
AC:
64
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
292
585
877
1170
1462
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Fanconi anemia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.